Radiofrequency ablation for hepatocellular carcinoma and liver metastases: Experience in Hospital La Paz

被引：0

作者：

Senent S.G. ^{[1
]}

Raposo C.G. ^{[2
]}

Marcos N.M. ^{[1
]}

Chavarri S.M. ^{[1
]}

Alonso G.C. ^{[1
]}

Martín A.O. ^{[1
]}

Cabral J.M.S. ^{[1
]}

Barón M.G. ^{[2
]}

机构：

[1] Department of Gastroenterology, La Paz University Hospital, Madrid 28046, C/Paseo de la Castellana

[2] Medical Oncology Service, La Paz University Hospital, Madrid 28046, C/Paseo de la Castellana

来源：

Clinical and Translational Oncology | 2006年 / 8卷 / 9期

关键词：

Hepatocellular carcinoma; Liver metastases; Percutaneous therapy; Radiofrequency ablation;

D O I：

10.1007/s12094-006-0040-x

中图分类号：

学科分类号：

摘要：

Introduction: Radiofrequency ablation for patients presenting with non-resectable primary or metastatic liver tumours seems to be a valid therapeutic alternative. In the present study, we show a descriptive list of indications, results and complications of Radiofrequency Ablation Technique for treating non-resectable solid hepatic tumours. Materials and methods: Twenty two patients were included in this study; eleven of them (50%) sustained liver metastases from colorectal adenocarcinoma, ten patients (45.5%) had hepatocellular carcinoma and 1 patient had insulinoma. Results: Local recurrence rate of hepatocellular carcinoma a was 22.7% and 27.3% for colorectal carcinoma, after a respective median follow-up of 21 and 14 months. Complications rate was 6.9% and technique-associated mortality rate was 0%. Conclusions: Radiofrequency ablation is an easy to make, safe and useful technique for the treatment of primary and metastatic liver tumours. © FESEO 2006.

引用

页码：688 / 691

页数：3

共 27 条

[1] Fernandez Castrogaudin J., Delgado Blanco E., Molina Perez E., Domínguez-Muñoz. Tratamiento percutáneo del carcinoma hepatocelular: ablación tumoral por radiofrecuencía. Evaluación de la respuesta terapéutica local, Gastroenterología Práctica., 14, pp. 8-17, (2005)
[2] Bruix J., Treatment of hepatocellular carcinoma, Hepatology, 25, pp. 259-262, (1997)
[3] Vilana R., Bruix J., Bru C., Ayuso C., Sole M., Rodes J., Tumor sizes determines the efficacy of percutaneous ethanol injection for treatment of small hepatocellular carcinoma, Hepatology, 16, pp. 353-357, (1992)
[4] Llovet J.M., Bruix J., Capurro S., Vilana R., Long-term survival after ethanol injection for small hepatocellular carcinoma in 100 cirrhotic patients. Relevance of maintained success, J Hepatol, 30, (1999)
[5] Livraghi T., Giorgio A., Marin G., Salmi A., de Sio I., Et al., Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection, Radiology, 197, pp. 101-108, (1995)
[6] Rossi S., Di Stasi M., Buscarini E., Et al., Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer, AJR, 167, pp. 759-768, (1996)
[7] Rossi S., Buscarini E., Garbagnati F., Et al., Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode, AJR, 170, pp. 1015-1022, (1998)
[8] Rossi S., Garbagnati F., Lencioni R., Et al., Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply, Radiology, 217, pp. 119-126, (2000)
[9] Curley S.A., Izzo F., Delrio P., Et al., Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients, Ann Surg, 230, pp. 1-8, (1999)
[10] Pearson A.S., Izzo F., Fleming R.Y., Et al., Intraoperative radiofrequency ablation or cryoablations for hepatic malignancies, Am J Surg, 178, pp. 592-599, (1999)

← 1 2 3 →